Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation, and Chronic Myeloid Leukemia Treatments.
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes
Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma
Age‐stratified machine learning identifies divergent prognostic significance of molecular alterations in AML
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Preclinical Efficacy of Tasquinimod in Myelodysplastic Neoplasms: Restoring Erythropoiesis and Mitigating Bone Loss
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Molecular and clinical presentation of <i>UBA1</i>-mutated myelodysplastic syndromes
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Acute promyelocytic leukemia: long-term outcomes from the HARMONY project
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes
Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with <i>KMT2Ar</i> or <i>NPM1</i> Alterations